Global Anti-aging Drugs Market Insights, Forecast to 2025

Publisher Name :
Date: 14-May-2019
No. of pages: 110
Inquire Before Buying

Aging is a natural part of human life. However, recent discoveries indicate that pharmacological approaches used for the improvement and possibly, for the delay of the aging process, might shed a new light on this topic. This might obviously contribute to the extension of the active life of older people and maintenance of their quality of life, which could consequently reduce both social and economic burden of each country, especially the developed ones.

According to the report, one of the major drivers for this market is Growing disposable income and healthcare expenditure in developing countries. Growing disposable income in developing countries such as India and China has attracted investors from around the world.

The global Anti-aging Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-aging Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Anti-aging Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-aging Drugs in these regions.

This research report categorizes the global Anti-aging Drugs market by top players/brands, region, type and end user. This report also studies the global Anti-aging Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Allergan

- Galderma

- Merz Pharma

- Sanofi

- Canbex Therapeutics

- Daewoong Pharmaceutical

- MMJ PhytoTech

- Revitacare

- SciVision Biotech

- Sun Pharmaceuticals

- Suneva Medical

- Syneron

- Valeant Pharmaceuticals

Market size by Product

- Injectable

- Oral

- Topical

Market size by End User

- Hospital

- Clinics

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Anti-aging Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Anti-aging Drugs market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Anti-aging Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Anti-aging Drugs submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti-aging Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-aging Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Anti-aging Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Anti-aging Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anti-aging Drugs Market Size Growth Rate by Product
1.4.2 Injectable
1.4.3 Oral
1.4.4 Topical
1.5 Market by End User
1.5.1 Global Anti-aging Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-aging Drugs Market Size
2.1.1 Global Anti-aging Drugs Revenue 2014-2025
2.1.2 Global Anti-aging Drugs Sales 2014-2025
2.2 Anti-aging Drugs Growth Rate by Regions
2.2.1 Global Anti-aging Drugs Sales by Regions
2.2.2 Global Anti-aging Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anti-aging Drugs Sales by Manufacturers
3.1.1 Anti-aging Drugs Sales by Manufacturers
3.1.2 Anti-aging Drugs Sales Market Share by Manufacturers
3.1.3 Global Anti-aging Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-aging Drugs Revenue by Manufacturers
3.2.1 Anti-aging Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Anti-aging Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Anti-aging Drugs Price by Manufacturers
3.4 Anti-aging Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-aging Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-aging Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-aging Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anti-aging Drugs Sales by Product
4.2 Global Anti-aging Drugs Revenue by Product
4.3 Anti-aging Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anti-aging Drugs Breakdown Data by End User
6 North America
6.1 North America Anti-aging Drugs by Countries
6.1.1 North America Anti-aging Drugs Sales by Countries
6.1.2 North America Anti-aging Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anti-aging Drugs by Product
6.3 North America Anti-aging Drugs by End User
7 Europe
7.1 Europe Anti-aging Drugs by Countries
7.1.1 Europe Anti-aging Drugs Sales by Countries
7.1.2 Europe Anti-aging Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-aging Drugs by Product
7.3 Europe Anti-aging Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Anti-aging Drugs by Countries
8.1.1 Asia Pacific Anti-aging Drugs Sales by Countries
8.1.2 Asia Pacific Anti-aging Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anti-aging Drugs by Product
8.3 Asia Pacific Anti-aging Drugs by End User
9 Central & South America
9.1 Central & South America Anti-aging Drugs by Countries
9.1.1 Central & South America Anti-aging Drugs Sales by Countries
9.1.2 Central & South America Anti-aging Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anti-aging Drugs by Product
9.3 Central & South America Anti-aging Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Anti-aging Drugs by Countries
10.1.1 Middle East and Africa Anti-aging Drugs Sales by Countries
10.1.2 Middle East and Africa Anti-aging Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anti-aging Drugs by Product
10.3 Middle East and Africa Anti-aging Drugs by End User
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Company Business Overview
11.1.3 Allergan Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Allergan Anti-aging Drugs Products Offered
11.1.5 Allergan Recent Development
11.2 Galderma
11.2.1 Galderma Company Details
11.2.2 Company Business Overview
11.2.3 Galderma Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Galderma Anti-aging Drugs Products Offered
11.2.5 Galderma Recent Development
11.3 Merz Pharma
11.3.1 Merz Pharma Company Details
11.3.2 Company Business Overview
11.3.3 Merz Pharma Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merz Pharma Anti-aging Drugs Products Offered
11.3.5 Merz Pharma Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Anti-aging Drugs Products Offered
11.4.5 Sanofi Recent Development
11.5 Canbex Therapeutics
11.5.1 Canbex Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Canbex Therapeutics Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Canbex Therapeutics Anti-aging Drugs Products Offered
11.5.5 Canbex Therapeutics Recent Development
11.6 Daewoong Pharmaceutical
11.6.1 Daewoong Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Daewoong Pharmaceutical Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Daewoong Pharmaceutical Anti-aging Drugs Products Offered
11.6.5 Daewoong Pharmaceutical Recent Development
11.7 MMJ PhytoTech
11.7.1 MMJ PhytoTech Company Details
11.7.2 Company Business Overview
11.7.3 MMJ PhytoTech Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 MMJ PhytoTech Anti-aging Drugs Products Offered
11.7.5 MMJ PhytoTech Recent Development
11.8 Revitacare
11.8.1 Revitacare Company Details
11.8.2 Company Business Overview
11.8.3 Revitacare Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Revitacare Anti-aging Drugs Products Offered
11.8.5 Revitacare Recent Development
11.9 SciVision Biotech
11.9.1 SciVision Biotech Company Details
11.9.2 Company Business Overview
11.9.3 SciVision Biotech Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 SciVision Biotech Anti-aging Drugs Products Offered
11.9.5 SciVision Biotech Recent Development
11.10 Sun Pharmaceuticals
11.10.1 Sun Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Sun Pharmaceuticals Anti-aging Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sun Pharmaceuticals Anti-aging Drugs Products Offered
11.10.5 Sun Pharmaceuticals Recent Development
11.11 Suneva Medical
11.12 Syneron
11.13 Valeant Pharmaceuticals
12 Future Forecast
12.1 Anti-aging Drugs Market Forecast by Regions
12.1.1 Global Anti-aging Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Anti-aging Drugs Revenue Forecast by Regions 2019-2025
12.2 Anti-aging Drugs Market Forecast by Product
12.2.1 Global Anti-aging Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Anti-aging Drugs Revenue Forecast by Product 2019-2025
12.3 Anti-aging Drugs Market Forecast by End User
12.4 North America Anti-aging Drugs Forecast
12.5 Europe Anti-aging Drugs Forecast
12.6 Asia Pacific Anti-aging Drugs Forecast
12.7 Central & South America Anti-aging Drugs Forecast
12.8 Middle East and Africa Anti-aging Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-aging Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Anti-aging Drugs Product Picture
Table Anti-aging Drugs Market Segments
Table Key Manufacturers Anti-aging Drugs Covered
Table Global Anti-aging Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Anti-aging Drugs Sales Market Share by Product 2014-2025
Figure Injectable Product Picture
Table Major Manufacturers of Injectable
Figure Oral Product Picture
Table Major Manufacturers of Oral
Figure Topical Product Picture
Table Major Manufacturers of Topical
Table Global Anti-aging Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Clinics
Figure Others
Figure Anti-aging Drugs Report Years Considered
Figure Global Anti-aging Drugs Market Size 2014-2025 (Million US$)
Figure Global Anti-aging Drugs Sales 2014-2025 (K Units)
Table Global Anti-aging Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Anti-aging Drugs Sales by Regions 2014-2019 (K Units)
Table Global Anti-aging Drugs Sales Market Share by Regions 2014-2019
Figure Global Anti-aging Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Anti-aging Drugs Sales Market Share by Regions
Table Global Anti-aging Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Anti-aging Drugs Revenue Market Share by Regions 2014-2019
Figure Global Anti-aging Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Anti-aging Drugs Revenue Market Share by Regions
Table Global Anti-aging Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Anti-aging Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Anti-aging Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Anti-aging Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Anti-aging Drugs Revenue Share by Manufacturers (2014-2019)
Figure Anti-aging Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Anti-aging Drugs Price (2014-2019) (USD/Unit)
Table Anti-aging Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Anti-aging Drugs Product Type
Table Date of International Manufacturers Enter into Anti-aging Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Anti-aging Drugs Sales by Product (2014-2019) (K Units)
Table Global Anti-aging Drugs Sales Share by Product (2014-2019)
Figure Global Anti-aging Drugs Sales Market Share by Product (2014-2019)
Figure Global Anti-aging Drugs Sales Market Share by Product in 2018
Table Global Anti-aging Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Anti-aging Drugs Revenue Share by Product (2014-2019)
Figure Global Anti-aging Drugs Revenue Market Share by Product (2014-2019)
Figure Global Anti-aging Drugs Revenue Market Share by Product in 2018
Table Anti-aging Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Anti-aging Drugs Sales by End User (2014-2019) (K Units)
Table Global Anti-aging Drugs Sales Share by End User (2014-2019)
Figure Global Sales Anti-aging Drugs Market Share by End User (2014-2019)
Figure Global Sales Anti-aging Drugs Market Share by End User in 2018
Figure North America Anti-aging Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Anti-aging Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Anti-aging Drugs Sales by Countries (2014-2019) (K Units)
Table North America Anti-aging Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Anti-aging Drugs Sales Market Share by Countries
Table North America Anti-aging Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Anti-aging Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Anti-aging Drugs Revenue Market Share by Countries
Figure United States Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Anti-aging Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Anti-aging Drugs Sales by Product (2014-2019) (K Units)
Table North America Anti-aging Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Anti-aging Drugs Market Share by Product
Table North America Anti-aging Drugs Sales by End User (2014-2019) (K Units)
Table North America Anti-aging Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Anti-aging Drugs Market Share by End User
Figure Europe Anti-aging Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Anti-aging Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Anti-aging Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Anti-aging Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-aging Drugs Sales Market Share by Countries
Table Europe Anti-aging Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Anti-aging Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Anti-aging Drugs Revenue Market Share by Countries
Figure Germany Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Anti-aging Drugs Sales by Product (2014-2019) (K Units)
Table Europe Anti-aging Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Anti-aging Drugs Market Share by Product
Table Europe Anti-aging Drugs Sales by End User (2014-2019) (K Units)
Table Europe Anti-aging Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Anti-aging Drugs Market Share by End User
Figure Asia Pacific Anti-aging Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Anti-aging Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Anti-aging Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Anti-aging Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-aging Drugs Sales Market Share by Countries
Table Asia Pacific Anti-aging Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Anti-aging Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Anti-aging Drugs Revenue Market Share by Countries
Figure China Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Anti-aging Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Anti-aging Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Anti-aging Drugs Market Share by Product
Table Asia Pacific Anti-aging Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Anti-aging Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Anti-aging Drugs Market Share by End User
Figure Central & South America Anti-aging Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Anti-aging Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Anti-aging Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Anti-aging Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-aging Drugs Sales Market Share by Countries
Table Central & South America Anti-aging Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Anti-aging Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Anti-aging Drugs Revenue Market Share by Countries
Figure Brazil Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Anti-aging Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Anti-aging Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Anti-aging Drugs Market Share by Product
Table Central & South America Anti-aging Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Anti-aging Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Anti-aging Drugs Market Share by End User
Figure Middle East and Africa Anti-aging Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Anti-aging Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Anti-aging Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Anti-aging Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-aging Drugs Sales Market Share by Countries
Table Middle East and Africa Anti-aging Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Anti-aging Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Anti-aging Drugs Revenue Market Share by Countries
Figure GCC Countries Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Anti-aging Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Anti-aging Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Anti-aging Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Anti-aging Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Anti-aging Drugs Market Share by Product
Table Middle East and Africa Anti-aging Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Anti-aging Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Anti-aging Drugs Market Share by End User
Table Allergan Company Details
Table Allergan Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Galderma Company Details
Table Galderma Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Galderma Recent Development
Table Merz Pharma Company Details
Table Merz Pharma Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merz Pharma Recent Development
Table Sanofi Company Details
Table Sanofi Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Canbex Therapeutics Company Details
Table Canbex Therapeutics Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Canbex Therapeutics Recent Development
Table Daewoong Pharmaceutical Company Details
Table Daewoong Pharmaceutical Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Daewoong Pharmaceutical Recent Development
Table MMJ PhytoTech Company Details
Table MMJ PhytoTech Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table MMJ PhytoTech Recent Development
Table Revitacare Company Details
Table Revitacare Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Revitacare Recent Development
Table SciVision Biotech Company Details
Table SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table SciVision Biotech Recent Development
Table Sun Pharmaceuticals Company Details
Table Sun Pharmaceuticals Anti-aging Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceuticals Recent Development
Table Suneva Medical Company Details
Table Syneron Company Details
Table Valeant Pharmaceuticals Company Details
Table Global Anti-aging Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Anti-aging Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Anti-aging Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Anti-aging Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Anti-aging Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Anti-aging Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Anti-aging Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Anti-aging Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Anti-aging Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Anti-aging Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Anti-aging Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Anti-aging Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Anti-aging Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Anti-aging Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Anti-aging Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Anti-aging Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Anti-aging Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Anti-aging Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Anti-aging Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Anti-aging Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Anti-aging Drugs Value Chain
Table Anti-aging Drugs Customers List
Table Anti-aging Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs